Research Project

Project Title:

A Phase 2, Open-Label, Basket Study of Atrasentan in Patients with Proteinuric Glomerular Diseases (The AFFINITY Study)

Project Type:

Clinical Trial, Enrolment ongoing

Disease group(s):

Hereditary glomerulopathies

Project Summary:

To evaluate the effect of atrasentan on proteinuria/albuminuria levels in subjects at risk of progressive loss of kidney function.

Lead principal investigator(s):

Marina Vivarelli, Rome

Co-investigator(s):

Laura Massella, Rome
Chiara Bettini, Rome

Project Period:

12/2022   -   12/2060

EudraCT Nr.:

2020-004176-18

« Back to research page